Clinical trials
Phase 3 Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
732 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 14 |
| 2001 | 11 |
| 2002 | 17 |
| 2003 | 10 |
| 2004 | 17 |
| 2005 | 19 |
| 2006 | 28 |
| 2007 | 27 |
| 2008 | 25 |
| 2009 | 26 |
| 2010 | 16 |
| 2011 | 24 |
| 2012 | 14 |
| 2013 | 18 |
| 2014 | 22 |
| 2015 | 30 |
| 2016 | 33 |
| 2017 | 23 |
| 2018 | 33 |
| 2019 | 24 |
| 2020 | 37 |
| 2021 | 38 |
| 2022 | 26 |
| 2023 | 33 |
| 2024 | 45 |
| 2025 | 46 |
| 2026 | 34 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 292 |
| Recruiting | 103 |
| Active, not recruiting | 97 |
| Unknown status | 96 |
| Terminated | 95 |
| Not yet recruiting | 28 |
| Withdrawn | 16 |
| Enrolling by invitation | 3 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 38 |
| AstraZeneca | 37 |
| Hoffmann-La Roche | 33 |
| Eli Lilly and Company | 25 |
| National Cancer Institute (NCI) | 20 |
| Bristol-Myers Squibb | 19 |
| Pfizer | 17 |
| Alliance for Clinical Trials in Oncology | 16 |
| Boehringer Ingelheim | 14 |
| Novartis Pharmaceuticals | 14 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 732 |
| Lung Neoplasms | 167 |
| Adenocarcinoma of Lung | 29 |
| Neoplasm Metastasis | 29 |
| Neoplasms | 28 |
| Carcinoma | 17 |
| Brain Neoplasms | 16 |
| Lung Diseases | 13 |
| Adenocarcinoma, Bronchiolo-Alveolar | 12 |
| Small Cell Lung Carcinoma | 12 |
Trials
Showing 26 to 50 of 732. Each trial links to its page on Pharma Observatory.
632 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.